Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-05

Clinical Trial Update: Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Obeticholic Acid with Vitamin E in non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Obeticholic acid (obeticholic acid)
  • Vitamin E (tocopherol)

Snippet

Sponsor: King Edward Medical University | Conditions: Non Alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED